YRD News and Press, Yirendai Ltd. American Depositary Shares each representing two From 07/11/19

Yirendai Ltd (YRD) Q1 2019 Earnings Conference Call July 10, 2019 20:00 ET Corporate Participants Lydia Yu - Investor Relations Ning Tang - Chief Executive Officer Dennis Cong - Chief Financial Officer Huan Chen - Chief Risk Officer Wei Wang - Chief Executive Officer, Yiren C...

Yirendai (NYSE: YRD ): Q1 GAAP EPS of $0.59 beats by $0.27 . Revenue of $295.1M beats by $56.59M . Press Release More news on: Yirendai Ltd., Earnings news and commentary, Financial stocks news,

BEIJING, July 10, 2019 (GLOBE NEWSWIRE) -- Yirendai Ltd. (NYSE: YRD) (“Yirendai” or the “Company”), a leading fintech company in China, today announced its unaudited financial results for the first quarter ended March 31, 2019 and the successful closing of the bu...

AIR , BBBY , PSMT , YRD For Seeking Alpha's full earnings season calendar, click here . More news on: AAR Corp., Bed Bath & Beyond Inc., PriceSmart, Inc., Earnings news and commentary,

BEIJING, June 24, 2019 (GLOBE NEWSWIRE) -- Yirendai Ltd. (NYSE: YRD) ("Yirendai" or the "Company"), a leading fintech company in China, announced that it plans to release its unaudited financial results for the first quarter ended March 31, 2019 after U.S. market closes on We...

Introduction Yirendai (YRD) is a Chinese peer to peer (P2P) fintech lending company, matching lenders with borrowers who are below the standard of credit issuance from Chinese retail banks, but nonetheless requires capital for personal expenses. Over 60% of YRD's FY 2018 revenues stem from...

It’s been more than a year since we first covered the Chinese Fintech sector . The industry has experienced/changed a lot in the past year, and we believe now would be a good time for an update. Fintech: One of the Largest Sectors for US-Listed Chinese Companies Starting 2017, we h...

BEIJING, April 29, 2019 (GLOBE NEWSWIRE) -- Yirendai Ltd. (NYSE: YRD) (“Yirendai” or the “Company”), a leading fintech company in China, announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2018 with the Securities and...

Proteon Therapeutics (NASDAQ: PRTO )  -83%  after vonapanitase flunks second late-stage study. More news on: Proteon Therapeutics, Inc., Reebonz Holding Limited, Castor Maritime Inc., Stocks on the move, Read more ...

Yirendai Ltd (YRD) Q4 2018 Earnings Conference Call March 25, 2019 07:00 AM ET Company Participants Lydia Yu - Director of Investor Relations Ning Tang - Founder, Chairman, and Chief Executive Officer of CreditEase and Chairman of the Yirendai Yihan Fang - Chief Executive Officer...